Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy
- David S. Miller1,
- Stephanie N. Nobmann2,
- Heike Gutmann3,
- Michael Toeroek3,
- Juergen Drewe3 and
- Gert Fricker2
- 1Laboratory of Pharmacology and Chemistry (D.S.M.), National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina; 2Institut fur Pharmazeutische Technologie und Biopharmazie (S.N.N., G.F.), Heidelberg, Germany; Divisions of 3Gastroenterology and Clinical Pharmacology, Department of Internal Medicine, and Department of Research (H.G., M.T., J.D.), University Clinic (Kantonsspital and Childrens Hospital) Basel, Switzerland
Abstract
To identify specific transporters that drive xenobiotics from central nervous system to blood, the accumulation of fluorescent drugs was studied in isolated capillaries from rat and pig brain using confocal microscopy and quantitative image analysis. Luminal accumulation of daunomycin and of fluorescent derivatives of cyclosporine A (CSA) and ivermectin was concentrative, specific, and energy-dependent (inhibition by NaCN). Transport was reduced by PSC 833, ivermectin, verapamil, CSA, and vanadate, but not by leukotriene C4(LTC4), indicating the involvement of P-glycoprotein. Luminal accumulation of the fluorescent organic anions sulforhodamine 101 and fluorescein methotrexate was also concentrative, specific, and energy-dependent. LTC4, chlorodinitrobenzene, and vanadate reduced transport of these compounds, but PSC 833 and verapamil did not, indicating the involvement of a multidrug resistance-associated protein (Mrp). Immunostaining localized P-glycoprotein and Mrp2 to the luminal surface of the capillary endothelium and quantitative polymerase chain reaction showed Mrp1 and Mrp2 expression. Finally, the HIV protease inhibitors saquinavir and ritonavir were potent inhibitors of transport mediated by both P-glycoprotein and Mrp. These results validate a new method for studying drug transport in isolated brain capillaries and implicate both P-glycoprotein and one or more members of the Mrp family in drug transport from central nervous system to blood.
Footnotes
-
Send reprint requests to: Dr. David S. Miller, LPC, NIH/NIEHS, P.O. Box 12233, Research Triangle Park, NC 27709. E-mail:miller{at}niehs.nih.gov
-
Supported by Grant CRG 960281 from the North Atlantic Treaty Organization and DFG FR1211.
- Abbreviations:
- ABC
- ATP-binding cassette
- Mrp
- multidrug-resistance protein
- CSA
- cyclosporin A
- NBDL
- N-ε-(4-nitrobenzofurazan-7-yl)-d-Lys8
- FL-MTX
- fluorescein methotrexate
- BO-IVER
- bodipy-ivermectin
- PCR
- polymerase chain reaction
- LTC4
- leukotriene C4
- GAPDH
- glyceraldehyde-3-phosphate dehydrogenase
-
- Received June 10, 1999.
- Accepted September 29, 2000.
- The American Society for Pharmacology and Experimental Therapeutics



